Covid19 Prevention & Care; a Cancer Specific Guideline Publisher Pubmed



Motlagh A^{1, 2} ; Yamrali M³ ; Azghandi S⁴ ; Azadeh P² ; Vaezi M⁴ ; Ashrafi F⁵ ; Zendehdel K⁶ ; Mirzaei H² ; Basi A⁷ ; Rakhsha A² ; Seifi S⁸ ; Tabatabaeefar M² ; Elahi A⁹ ; Pirjani P¹⁰ Show All Authors
Source: Archives of Iranian Medicine Published:2020

Abstract

On March 11th 2020, the coronavirus outbreak was declared a pandemic by the WHO. One of the groups that is considered high risk in this pandemic are cancer patients as they are treated with a variety of immune system suppressor treatment modalities and this puts them in a great risk for infectious disease (including COVID-19). Therefore, cancer patients require higher level measures for preventing and treating infectious diseases. furthermore, cancer patients may bear additional risk due to the restriction of access to the routine diagnostic and therapeutic services during such epidemic. Since most of the attention of health systems is towards patients affected with COVID-19, the need for structured and unified approaches to COVID-19 prevention and care specific to cancer patients and cancer centers is felt more than ever. This article provides the recommendations and possible actions that should be considered by patients, their caregivers and families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. We pursued two major goals in our recommendations: First, limiting the exposure of cancer patients to medical environments and second, modifying the treatment modalities in a manner that reduces the probability of myelosuppression such as delaying elective diagnostic and therapeutic services, shortening the treatment course, or prolonging the interval between treatment courses. © 2020 Academy of Medical Sciences of I.R. Iran. All rights reserved.